InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,043.16
(
-0.56%
)
US TECH 100
16,889.60
(
-1.00%
)
Dow Jones
38,098.22
(
-0.94%
)
Brent Oil
87.21
(
-0.01%
)
Bitcoin
64,621.78
(
0.53%
)
Post# of 19
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BioSpecialist

Send PM Follow Ignore
Followers 129
Posts 2150
Boards Moderated 1
Alias Born 12/27/2007

BioSpecialist

Re: None

Friday, 09/25/2009 2:24:08 PM

Friday, September 25, 2009 2:24:08 PM

Post# of 19
Senetek PLC Rated 'Strong Buy' by Wharton Capital Management

Senetek PLC (Nasdaq: SNTKY) that New York City-based Wharton Capital Management Inc., has initiated coverage of Senetek with a "strong buy" rating on the company.

"Our price target is $10," said Wharton Capital Management analyst Rick Joshi. "We believe that Senetek is grossly undervalued at current levels.

"Senetek has a profitable Cosmeticals business with substantial and rapidly growing sales," Joshi continued. "It has in the late stages of development a novel biopharmaceutical for treating ED (Erectile Dysfunction) with a proprietary, advanced drug delivery system that targets
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up